Suppr超能文献

[艾莫昔平综合疗法对糖尿病性视网膜病变病程的影响]

[Effects of complex therapy with emoxipin on the course of diabetic retinopathy].

作者信息

Kozlov S A, Khyshiktuev B S, Logunov N A

出版信息

Vestn Oftalmol. 2003 Mar-Apr;119(2):28-30.

Abstract

The efficacy of 1% emoxipin solution (eye drops) in the nonproliferative stage of diabetic retinopathy was studied. The inhibition of lipid peroxidation and an enhancement of antioxidizing guard were observed both after the therapy by the above preparation and 3 months later. It was concluded that emoxipin was effective for leveling the biochemical violations in the "lipid peroxidation--antioxidants" system of lachrymal fluid in patients with the nonproliferative stage of diabetic retinopathy. The prescription of emoxipin eye drops can enhance the efficacy of therapy at the early stages of the disease.

摘要

研究了1%艾地苯醌溶液(滴眼液)在糖尿病视网膜病变非增殖期的疗效。在使用上述制剂治疗后及3个月后,均观察到脂质过氧化受到抑制且抗氧化保护作用增强。得出结论:艾地苯醌对糖尿病视网膜病变非增殖期患者泪液“脂质过氧化-抗氧化剂”系统中的生化异常具有调节作用。开具艾地苯醌滴眼液可提高疾病早期的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验